Loss of Rho function in the thymus is accompanied by the development of thymic lymphoma

Oncogene

Volumn 19, Issue 1, 2000, Pages 13-20

  Cleverley, S C ^a   Costello, P S ^a   Henning, S W ^a,b   Cantrell, D A ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C3 transferase; Lymphoma; Rho; Thymus; Transformation

Indexed keywords

ACTIN; CLOSTRIDIUM TOXIN; RHO FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOSKELETON; EFFECTOR CELL; FIBROBLAST; LYMPHOID CELL; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; T LYMPHOCYTE; THYMUS; THYMUS LYMPHOMA;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM;

EID: 0034610778     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203259     Document Type: Article

References (23)

1. Abraham KM, Levin SD, Marth JD, Forbush KA and Perlmutter RM. (1991). Proc. Nat. Acad. Sci. USA, 88,3977-3981.
2. Aktories K, Roesner U, Balschke U and Chatwal S. (1988). Eur. J. Biochem., 172, 445.
3. Badiani P, Corbella P, Kioussis D, Marvel J and Weston K. (1994). Gen. Develop., 8, 770-782.
4. Badiani PA, Kioussis D, Swirsky DM, Lamport IA and Weston K. (1996). Oncogene, 13, 2205-2212.
5. Bronson RT. (1990). In: Genetic Effects on Aging II, DE Harrison. (ed.), Telford Press Inc. Caldwell: New Jersey, pp. 279-358.
6. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
7. Gallandrini R, Henning S and Cantrell DA. (1997). Immunity, 7, 163-174.
8. Henning S, Galandrini R, Hall A and Cantrell DA. (1997). EMBO. J, 16, 2397-2407.
9. Henning SW and Cantrell DA. (1998). Curr. Opin. Immun., 10, 322-329.
10. Hill CS, Wynne J and Treisman R. (1995). Cell, 81, 1159-1170.
11. Hunter T. (1991). Cell, 64, 249-270.
12. Itoh K, Yoshioka K, Akedo H, Uehata M, Ishizaki T and Narumiya S. (1999). Nature Med., 5, 221-225.
13. Ma A, Pena JC, Chang B, Margosian E, Davidson L, Alt FW and Thompson CB. (1995). Proc. Natl. Acad. Sci. USA, 92, 4763-4767.
14. Olson MF, Ashworth A and Hall A. (1995). Science, 269, 1270-1272.
15. Olson MF, Paterson HF and Marshall CJ. (1998). Nature, 394, 295-299.
16. Owen MJ and Venkitaraman AR. (1996). Curr. Opin. Immunol., 8, 191-198.
17. Prendergast GC, Khosravi Far R, Solski PA, Kurzawa H, Lebowitz PF and Der CJ. (1995). Oncogene, 10, 2289-2296.
18. Qiu RG, Chen J, McCormick F and Symons M. (1995). Proc. Natl. Acad. Sci. USA, 92, 11781-11785.
19. Ridley AJ and Hall A. (1992). Cell, 70, 389-399.
20. Rubin EJ, Gill MD, Bouquet P and Popoff MR. (1988). Mol. Cell. Biol., 8, 418-426.
21. Sahai E, Ishizaki T, Narumiya S and Treisman R. (1999). Curr. Biol., 9, 136-145.
22. van Lohuizen M, Verbeck S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T and Berns A. (1989). Cell, 56, 673-682.
23. Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL and Der CJ. (1998). Oncogene, 17, 1415-1438.